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Impairment of insulin signaling on diabetes mellitus has been related to cardiovascular
dysfunction, heart failure, and sudden death. In human endothelium, cationic amino acid
transporter 1 (hCAT-1) is related to the synthesis of nitric oxide (NO) and insulin has a
vascular effect in endothelial cells through a signaling pathway that involves increases in
hCAT-1 expression and L-arginine transport. This mechanism is disrupted in diabetes, a
phenomenon potentiated by excessive accumulation of reactive oxygen species (ROS),
which contribute to lower availability of NO and endothelial dysfunction. On the other
hand, electrical remodeling in cardiomyocytes is considered a key factor in heart failure
progression associated to diabetes mellitus. This generates a challenge to understand
the specific role of insulin and the pathways involved in cardiac function. Studies
on isolated mammalian cardiomyocytes have shown prolongated action potential in
ventricular repolarization phase that produces a long QT interval, which is well explained
by attenuation in the repolarizing potassium currents in cardiac ventricles. Impaired insulin
signaling causes specific changes in these currents, such a decrease amplitude of the
transient outward K+ (Ito) and the ultra-rapid delayed rectifier (IKur) currents where,
together, a reduction of mRNA and protein expression levels of α-subunits (Ito, fast;
Kv 4.2 and IKs; Kv 1.5) or β-subunits (KChIP2 and MiRP) of K+ channels involved
in these currents in a MAPK mediated pathway process have been described. These
results support the hypothesis that lack of insulin signaling can produce an abnormal
repolarization in cardiomyocytes. Furthermore, the arrhythmogenic potential due to
reduced Ito current can contribute to an increase in the incidence of sudden death in heart
failure. This review aims to show, based on pathophysiological models, the regulatory
function that would have insulin in vascular system and in cardiac electrophysiology.
Keywords: insulin, L-arginine, nitric oxide, endothelium, cardiac potassium channels, ventricular repolarization,
heart failure, insulin resistance
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GENERAL OVERVIEW OF
CARDIOVASCULAR REGULATION BY
INSULIN IN HEALTH AND DISEASE
Insulin is a peptide hormone produced by the β cells, of the
islets of Langerhans. Functionally, is the most potent anabolic
hormone, promoting the synthesis and storage of carbohydrates,
lipids and proteins, while inhibiting their degradation and release
into circulation. This hormone stimulates the uptake of glucose,
amino acids, and fatty acids; and increases the expression of
enzymes involved in the glycogen, lipid, and protein synthesis.
At the same time, it reduces the activity of the enzymes that
catalyse degradation of same molecules (Saltiel and Kahn, 2001).
Cellular effects of insulin are mediated by the activation of insulin
receptors (IRs A/B), and a signaling pathway involved in the
regulation of nutrients metabolism, mitochondrial biogenesis,
cellular grown, proliferation, differentiation, and migration
(Nystrom and Quon, 1999). IRs are glycoproteins consisting of
an extracellular α-subunit (135 kDa) and a transmembrane β-
subunit (95 kDa). These receptors are allosteric enzymes in which
the α-subunit regulates tyrosine kinase activity of the β-subunits.
The binding of insulin to the α-subunit results in dimerization,
forming the α2β2 complex in the plasma membrane. The
complex α2β2 generates the autophosphorylation of β-subunit
at tyrosine (Tyr) 1158 (Tyr1158), Tyr1162, and Tyr1163, the first
step in the activation cascade induced by insulin (Patti and Kahn,
1998). Phosphorylation of IR induces the tyrosine kinase activity
toward insulin receptor substrate (IRS) 1 (IRS-1) or 2 (IRS-
2), generating binding sites for Src homology 2 (SH2) domain
proteins, including phosphatidylinositol 3-kinase (PI3K), RAS
guanine nucleotide exchange factor complex known as growth
factor receptor-bound protein 2/son of sevenless (GRB2/SOS),
and SH2 domain-containing protein tyrosine phosphatase-2
(SHP2) and other SH2 proteins (Copps and White, 2012). These
proteins provide specific docking sites for the recruitment of
downstream signaling proteins, leading to activation of mitogen-
activated protein kinase (MAPK), protein kinase B (PKB/Akt)
and protein kinase C (PKC) signaling cascades (White, 2003;
Schultze et al., 2012).
Abbreviations: Ach, acetylcholine; AP, action potential; AsODNs, antisense
oligonucleotides; BH4, tetrahydrobiopterin; Cav, voltage-gated calcium
channel; CIRKO, cardiac-specific insulin receptor knock-out; DCM, Diabetic
Cardiomyopathy; DM, Diabetes Mellitus; DOCK1, dedicator of cytokinesis
protein 1; EC, electrocardiogram; eNOS, endothelial NO synthase; GAB1, Grb-2
associated protein; HAEC, human aortic endothelial cells; hCAT-1, cationic
aminoacid transporter; HEKC, human embryonic kidney cells; HUVEC, human
umbilical vein endothelial cells; IK, delayed rectifier potassium channel; IKr,
rapidly activating delayed rectifier potassium channel; IKs, slowly activating
delayed rectifier potassium channel; IKur, ultra-rapid potassium current; IR,
Insulin receptor; IRS, insulin receptor substrate; Ito, transient outward potassium
current; KChIP2, voltage-gated potassium (Kv) channel-interacting proteins; Kir,
inwardly rectifying potassium channels; Kv, voltage-gated potassium channel;
MAPK, Mitogen-activated protein kinases; MiRP, MinK-related peptide 1;
Nav, voltage-gated sodium channel; NE, norepinephrine; NO, nitric oxide;
PI3K, phosphatidylinositide-3-kinase; PKC, protein kinase C; QTc, heart rate-
corrected QT interval; SHC, Src homology 2-domain containing protein; STZ,
streptozotocin; T1DM, Type 1 Diabetes Mellitus; T2DM, Type 2 Diabetes Mellitus;
Tyr, tyrosine amino acid; WHO, World Health Organization.
Since the early nineties, the cardiovascular actions of insulin
have been studied in humans, and the main information
was collected in several works published by Alain Baron and
Helmut Steinberg. In 1990, in a study made in obese and lean
subjects determined a correlation between insulin resistance
(hyperglycaemia and hyperinsulinemia), and lack of vasodilatory
effects of insulin in leg blood flow (LBF). These obese subjects
showed a lower capacity for uptake D-glucose and changes in
cardiac function, such as reduction in cardiac index [cardiac
output (CO)/body surface area] and stroke volume (SV) without
change in heart rate (HR) (Baron et al., 1990). Authors
concluded that insulin resistance could be a result of insulin’s
actions both in glucose uptake and hemodynamic regulation,
highlighting the in vivo role of insulin as an endocrine regulator
of cardiovascular physiology. Later, healthy subjects under a
protocol of euglycemic hyperinsulinemia showed increases of
CO, SV, HR, and LBF; and decreases of mean arterial pressure
(MAP), systemic vascular resistance (SVR), and leg vascular
resistance (LVR). Correlation analysis showed that the insulin-
mediated glucose uptake is inversely proportional to MAP or
SVR, supporting the hemodynamic basis for insulin resistance
(Baron et al., 1993). The effects of insulin are part of physiological
regulation of cardiovascular system, with a delicate interaction
with other signals, like norepinephrine (NE) and acetylcholine
(Ach). Obese insulin-resistant subjects show more sensitivity to
contractile effects of NE, and lower clearance of NE in response
to insulin (Baron et al., 1994). More recently, a reduction was
shown in Ach-dependent forearm blood flow in obese patients,
but this effect disappears in the group of obese subjects without
metabolic syndrome (Schinzari et al., 2015). Even though it is
not possible to discard a deleterious effect of obesity per se
on the cardiovascular system, mechanisms that we discuss in
this review show that insulin resistance could be a primary
cause of cardiovascular disease in metabolic disorders, leading
to a deterioration of endothelium-dependent vasodilatation and
higher sensibility to vasoconstrictors, like NE or other locally
released molecules. The accumulated evidence shown by the
literature makes it possible to establish that insulin-dependent
blood flow increments are blunted in obese, and type 2 diabetes
mellitus (T2DM) patients, conditions associated with insulin
resistance. Physiological regulation of blood flow by insulin
depends on a mechanism that involves the activation of PI3K,
PKB, and nitric oxide (NO) synthesis (Baron, 2002; Steinberg
and Baron, 2002). Due to the increasing prevalence of diabetes
and insulin resistance, a main objective of this article is to make a
critical review of physiological mechanisms regulated by insulin
both in vasculature and in the heart. Thus, we can propose a
hypothesis for pathological mechanisms of cardiovascular disease
in diabetes or insulin resistance.
Diabetes mellitus (DM) is characterized by chronic
hyperglycaemia which results from defects in insulin secretion
(type 1 DM), insulin action (T2DM), or both (WHO, 1998).
Diabetes is a common disease that affects ∼382 million people
worldwide, and the costs to society are high and escalating. By
the end of 2013, diabetes caused 5.1 million deaths and cost
USD 548 billion in healthcare spending (IFD, 2013). Although
treatment has been improved over the last decades, diabetes is
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related with several complications like acute hyperglycaemic or
hypoglycaemic events, kidney disease, eye disease, peripheral
vascular disease, coronary artery disease, cerebrovascular disease,
and congestive heart failure (Bethel et al., 2007).
Cardiovascular diseases (CVD) represent the leading
causes of morbidity and mortality in patients with diabetes
(Gregg et al., 2014), with cardiac and vascular dysfunctions
as key steps of the pathophysiological mechanism. Vascular
dysfunction is primarily caused by endothelial dysfunction,
a phenomenon related with deterioration in the capacity of
these cells to synthesize NO. NO is synthesized from the
semi-essential cationic amino acid L-arginine and molecular
oxygen (O2) by endothelial NO synthase (eNOS), leading to
the formation of NO and the neutral amino acid L-citrulline
(Palmer et al., 1988). The enzyme depends on several cofactors,
including Ca2+/calmodulin complex, tetrahydrobiopterin
(BH4), nicotinamide adenine dinucleotide phosphate (NADPH),
flavin adenine dinucleotide (FAD), and flavin mononucleotide
(FMN) (Knowles and Moncada, 1994; Sessa, 1994). In absence
of NO signaling there is a disturbance in vascular homeostasis,
triggering a series of events leading to pathologies like as
hypertension, hypercholesterolemia, renal vascular insufficiency,
and chronic heart failure (Vanhoutte, 2003; Wierzbicki et al.,
2004; Yang et al., 2007). As mentioned above, several studies in
diabetic patients have demonstrated deficiency in endothelium-
dependent vasodilation, a disturbance that generates an
imbalance in vascular tone, which ultimately leads to the
development of endothelial dysfunction (Williams et al., 1996;
Rask-Madsen and King, 2007). Mechanisms underlying the
decrease in NO-dependent dilatation in diabetes include
decreased bioavailability of tetrahydrobiopterin (BH4) cofactor
and uncoupling of eNOS (Cai et al., 2005), increased activity
of arginase (an enzyme that competes with the eNOS for L-
arginine; Vanhoutte and Tang, 2008), high levels of asymmetric
dimethylarginine (ADMA, endogenous inhibitor of eNOS; Xiong
et al., 2003); increased production of superoxide anion (O−2 )
and peroxynitrite (ONOO−) synthesis (Cosentino et al., 2003;
Quijano et al., 2007), inactivation of NO by advanced glycation
end products (Gao et al., 2008) and abnormal responses of
vascular smooth muscle cells (VSMC) (Lesniewski et al., 2008;
Shi and Vanhoutte, 2008).
On the other hand, a main cardiac disorder is diabetic
cardiomyopathy (DCM), a pathology associated with alterations
in molecular metabolism and structure of cardiomyocytes (Fang
et al., 2004). These changes include, among others, a ventricular
electric remodeling characterized by long-term alterations in
ion channel activity that could be a compensatory or adaptive
mechanism (Casis and Echevarria, 2004). Electrical remodeling
has been related with contractile failure due to abnormal increase
of intracellular Ca2+ concentration or to arrhythmias that lead to
sudden death (Straus et al., 2006). Most electrical disturbances
are related to the abnormal repolarization of cardiac action
potential (Shimoni et al., 2004). Electrophysiological studies
have clearly identified the different types of voltage-dependent
currents (inward or outward currents), which contribute to the
repolarization phase in the mammalian myocardium (Nerbonne
and Kass, 2005). Outward currents are clearly differentiated
and cardiac myocyte express voltage-dependent K+ channels
(Kv) that contribute to the development of action potential
(Nerbonne, 2000). Changes in the functional properties of
the Kv channels can generate dramatic effects in myocardial
action potential, and also in the normal cardiac rhythm
generation (Lengyel et al., 2007). Cardiovascular complications in
diabetes have been associated to a series of electrocardiographic
disturbances, such as QT interval prolongation, even in short-
term diabetes (Veglio et al., 2002a,b; Zhang et al., 2011).
Experimental evidence suggests that specific remodeling of some
K+ channels in the ventricle is related with these alterations
(Casis and Echevarria, 2004).
INSULIN REGULATION OF VASCULAR
SYSTEM
Relevance of L-Arginine Transport in
Vascular Physiology
In endothelial cells, uptake of the substrate L-arginine for NO
synthesis is mediated by transport systems called y+, y+L,
b0,+, and B0,+. The main transport system involved in this
process is the system y+, responsible for ∼85% of L-arginine
transport in physiological state (Devés and Boyd, 1998). This
system includes the family of proteins known as cationic amino
acids transporters (CATs), formed by CAT-1, CAT-2A, CAT-2B,
CAT-3, and CAT-4 (Verrey et al., 2004; Casanello et al., 2007).
Members of the CATs family are encoded by genes SLC7A 1,
2, 3, and 4 (Verrey et al., 2004). CAT-1, encoded by SLC7A1
gene, is ubiquitously expressed, while CAT-2A and CAT-3 are
constitutively expressed in liver and brain, respectively. CAT-2B
is induced under inflammatory conditions in a variety of cells
including T cells and macrophages. The CAT-4 gene sequence
is 41–42% identical to the other members of the family CATs,
but its transport activity has not been described. The function
of CATs was suggested because of their structural similarity
to Saccharomyces cerevisiae, permease for L-histidine and L-
arginine. Its function was verified by expression in Xenopus
laevis oocytes for kinetic transport studies (Closs et al., 1997).
CAT-1, CAT-2B, and CAT-3 are Na+ independent transporters,
presenting medium affinity for its substrate (Km ∼50–250µM),
whereas CAT-2A has low affinity for cationic amino acids
(Km ∼2–5mM) (Devés and Boyd, 1998; Palacín et al., 1998;
Mann et al., 2003).
In cytoplasm, L-arginine is used for synthesis of proteins,
NO, urea, creatine, agmatine, polyamines, and other molecules.
Intracellular concentration of L-arginine is near to 1mM, but
the Km of eNOS by L-arginine is ∼3µM and, as mentioned,
the Km of hCAT-1/2B for L-arginine is ∼50–250µM (Shin et al.,
2011). These inconsistencies between cytoplasmic concentrations
of L-arginine and the affinity for substrate of L-arginine/NO
system, constitutes the “L-arginine paradox.” This paradox is
under discussion among researchers, especially given the growing
relevance of L-arginine transport from extracellular space and
the concept of compartmentalization of different pools of L-
arginine (Karbach et al., 2011; Simon et al., 2013). In a simple but
very elegant experiment, Shin et al. demonstrated that L-arginine
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transport mediated by a facilitated diffusion system is absolutely
necessary for NO synthesis: when EA.hy926 endothelial cells
are incubated with modified L-arginine, which has the ability to
enter cells by passive diffusion, eNOS is not able to synthesize
NO. Additionally, in knockdown cells for hCAT-1 (induced by
siRNA), L-citrulline synthesis is significantly reduced, showing
the relevance of this specific transporter (Shin et al., 2011).
This evidence is supported by hCAT-1 localization studies. In
porcine aortic endothelial cells (PAEC) CAT-1 colocalize with
eNOS and caveolin-1 (Cav-1, structural protein of caveolae;
McDonald et al., 1997). The subcellular localization through
overexpression of CAT-1 fused to green fluorescent protein
(GFP) has been studied in different cell lines (Closs et al., 2006).
In hamster kidney baby cells (HKB) it has been noted that
CAT-1-GFP is localized predominantly in caveolin associated
domains in plasma membrane (Lu and Silver, 2000). In another
study, CAT-1-EGFP was mainly found in intracellular vesicles
of U373MG, human glioblastoma cells, and to a lesser extent
a lesser extent in the plasma membrane (Wolf et al., 2002). In
Madin-Darby canine kidney epithelial cells (MDCK) and human
embryonic kidney 293 cells (HEK293), the expression of CAT-
1-GFP was detected, predominantly in the basolateral plasma
membrane (Cariappa et al., 2002; Kizhatil and Albritton, 2002).
Meanwhile, more research into HEK293 showed that mCAT-1-
GFP is located in filopodia, and near to Golgi (Masuda et al.,
1999). Recently, Guo et al. showed that CAT-1-GFP it expressed
in plasma membrane in colocalization with VE-caherin and the
authors propose that CAT-1 have a role as cellular adhesion
molecule (CAM) and that the incubation with extracellular L-
arginine augments L-arginine transport via promoting the CAT-
1 shift from endothelial cells junctions to the free surface of
ECs (Guo et al., 2015). Therefore, the L-arginine paradox has a
potential explanation in the characteristics of CAT-1 cell surface
expression, generating functional clusters for ensure an adequate
supply of L-arginine for eNOS activity. Due to their physiological
relevance, we focus on determining changes induced by insulin
and/or diabetes on activity and expression of CAT-1.
Regulation of hCAT-1 by Insulin in
Normoglycaemic or Hyperglycaemic
Environment
Insulin increases the mRNA expression levels of hCAT-1 and
hCAT-2B in human umbilical vein endothelial cells (HUVEC),
correlates with high rate of L-arginine transport and NO
synthesis (González et al., 2004) in a mechanism that involves
high abundance of the protein in the plasma membrane
(González et al., 2011). Insulin exerts a vasodilatory effect
(González et al., 2011; Guzmán-Gutiérrez et al., 2012) through
a signaling pathway involving PI3K, PKB/Akt, and MAPK
activity that activates hCAT-1 and eNOS in endothelial cells
(González et al., 2004). It has been described that this stimulation
by insulin is caused by the activation of the promoter of
the SLC7A1, gene encoding hCAT-1, via a mechanism that
involves multiple binding sequences for the transcriptional factor
specificity protein 1 (Sp1), located between 117 and 105 upstream
base pairs from the transcription start site (TSS) (González
et al., 2011). The SLC7A1 promoter belongs to the TATA-
less group, so binding sites for Sp1 located near the TSS
would be responsible for both basal expression and regulation
of gene expression to stimulation by growth factors (Sobrevia
and González, 2009). These effects have been observed with
physiologic concentrations of insulin (0.1–10 nM), so we propose
that the expression of SLC7A1 and hCAT-1 activity would be
under a tonic regulation by physiological levels of plasma insulin.
Moreover, it is reported that similar concentrations of insulin
(1µM) induces an acute (5min) increase of L-arginine transport
by a mechanism dependent on PI3K activity and PKC in human
aortic endothelial cells (HAEC) (Kohlhaas et al., 2011)
As was mentioned above, diabetes is related with
hyperglycaemia and insulin resistance, which are conditions
that stimulate the oxidative stress in vasculature. Furthermore,
exposure of HUVEC to high extracellular concentrations of
D-glucose increases the synthesis of O−2 dependent of NAD(P)H
oxidase, which reacts with the NO to generate ONOO−,
contributing to endothelial dysfunction (Sobrevia and González,
2009; González et al., 2015). Long-term incubation (24 h) of
HUVEC with 25mM D-glucose increases the transport of
L-arginine and cGMP accumulation in a similar magnitude to
that observed in HUVEC from pregnancies with gestational
diabetes mellitus (Sobrevia et al., 1996, 1997). Increased transport
of L-arginine in both chronic incubation with D-glucose and
gestational diabetes has been linked to increased mRNA levels
for hCAT-1 and eNOS activity (Vásquez et al., 2004, 2007). In
HAEC, prolonged incubation (7 days) with 25mM D-glucose
induces decreased eNOS activity (determined by nitrite content)
and lower abundance of the protein and mRNA level (Furfine
et al., 1994). This effect is associated with decreased activity
of eNOS promoter (Srinivasan et al., 2004). In HUVEC,
the hyperglycaemic environment induces an increase in the
abundance of the eNOS protein (Vásquez et al., 2007), an effect
that would be associated with the activity of a signaling pathway
involving the PI3K and Akt. It has also been shown that in
BAEC, there is a reduced production of insulin-dependent NO
when cells were incubated with high extracellular concentration
of D-glucose, an effect that seems to depend on a signaling
pathway involving the type 1 insulin receptor (IR-1), PI3K and
the inhibitor of nuclear factor kappa-B kinase subunit beta
(IKKβ) (Kim et al., 2006). Furthermore, increased production
of cGMP induced by D-glucose in HUVEC is blocked by
incubating the cells with 1 nM insulin (Sobrevia et al., 1997);
and the incubation with 1 nM insulin (8 h) is sufficient to block
the effect of D-glucose on the decrease of adenosine transport
(Muñoz et al., 2006), an important vasoactive nucleoside (San
Martín and Sobrevia, 2006). More recently, González et al. (2015)
demonstrated that high extracellular concentration of D-glucose
increases the expression of hCAT-1 and L-arginine transport,
inducing high synthesis of NO associated with NADPH oxidase-
dependent O−2 synthesis in HUVEC. On other hand, insulin (in
normoglycaemic environment) increases L-arginine transport
and NO synthesis without changes in O−2 levels, showing a
physiological response that results in relaxation of umbilical
vein (González et al., 2011). Interestingly, the effect of high
D-glucose is associated with high contractile response to U46619
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(thromboxane A2 analog) and hydrogen peroxide (H2O2).
Co-incubation with insulin recovers the adequate response to
vasoconstrictors and decreases the NADPH oxidase-dependent
ROS (González et al., 2015). These mechanisms induced by high
D-glucose could be responsible for endothelial dysfunction in
diabetes, a scenario in which the L-arginine andNO convert from
“good guys” to “bad guys” in company with high levels of ROS. In
these conditions, insulin reduces the oxidative stress to improve
bioavailability of NO, as long as the endothelial cell retains its
capacity to respond appropriately to the hormone (Figure 1).
In fact, in diabetic patients there is a significant reduction of
forearm blood flow in response to insulin infusion, and an
increase in L-arginine clearance (L-arginine incorporation to
the tissue) during insulin infusion was 41% less in diabetic
subjects compared to controls after adjusting for covariates age,
BMI, MAP, and HDL cholesterol (Rajapakse et al., 2013). The
data discussed in this section confirm the potential association
between T2DM (and gestational diabetes), insulin resistance
and endothelial dysfunction. Hence, further research must be
focused on detailed mechanisms that regulate the cardiovascular
actions of insulin in other states, such as hypertension and heart
failure. Following this principle, in the second part of this article
we review the effects of disturbances in cardiac insulin signaling.
INSULIN REGULATION OF CARDIAC
FUNCTION
Overview About Action Potential of
Cardiomyocytes
Normal mechanical function of the heart in mammals depends
on proper electrical functioning, which is reflected in the
sequential activation of pacemaker cells and subsequent
electrical propagation through the ventricles. Coordinated
electrical functioning of the heart is recorded by a
surface electrocardiogram (ECG). Propagation activity and
electromechanical coordination of ventricles also depends
on coupling among cells, mediated by gap junctions (Kanno
and Saffitz, 2001). Generation of action potential (AP) in
myocardium results from sequential activation and inactivation
of ion channels, which can lead input currents (Na+ and
Ca2+) and an output repolarization currents (K+) (Figure 2)
(Antzelevitch and Dumaine, 2002; Nerbonne and Kass, 2005).
AP differ in distinct regions of the heart, and contribute to
the spreading of excitation way through the myocardium and the
subsequent generation of normal heart beat (Kléber and Rudy,
2004). Changes in functional properties, or in the expression
of ion channels in the myocardium, as a result of mutations
(Antzelevitch, 2003) or myocardial diseases (Cesario et al., 2006),
can lead to changes in the AP, synchronization or spread,
including the heart’s predisposition to potentially life-threatening
arrhythmias (Akar et al., 2000; Casis et al., 2000; Casis and
Echevarria, 2004). Given the clinical relevance of heart rhythm,
it is of considerable interest to analyse the cellular and molecular
mechanisms that contribute to the generation and maintenance
of normal heart rhythm. Animal non-human studies suggests
that small changes in time- and voltage-dependence properties of
ion channels, in the myocardial sarcolemma, may have profound
effects in both the action potentials time as well in the refractory
period and rhythmicity (Delmar, 1992; Delisle et al., 2004).
In atrial myocytes, ventricular myocytes and Purkinje fibers,
the onset of AP is fast (Phase 0) and given principally by
voltage-dependent Na+ (Nav) channels activity (Fozzard, 2002).
In contrast, in pacemaker cells of sino-atrial (SA) node (SAN)
and atrio-ventricular (AV) node (AVN), this phase 0 is markedly
slower. Phase 0 in Purkinje fibers and myocytes is followed
by a transient repolarization (phase 1), reflecting Nav channel
inactivation and the activation of the fast transient voltage-
gated outward K+ current (Ito, f) (Niwa and Nerbonne, 2010).
This transient repolarization, which can be quite prominent
in Purkinje and ventricular cells, influences the shape and
the time of the action potential plateau (phase 2). Plasma
membrane depolarization also activates voltage-gated Ca2+
(Cav) currents, and the subsequent influx of Ca2+ through L-
type Cav channels, during the phase 2 (plateau), triggering the
excitation-contraction coupling in myocardium (Bers and Perez-
Reyes, 1999). The driving force for K+ eﬄux is high during
the plateau phase, and when Cav channels are inactivated, the
outward K+ currents predominate, resulting in repolarization
(phase 3). As a result, the voltage of plasma membrane returns
to the resting potential. In contrast to Nav and Cav currents,
there are multiple types of voltage-gated K+ (Kv) currents, as
well as non-voltage-gated, inwardly rectifying K+ (Kir) currents
(Figure 2 and Table 1). At least two types of transient outward
currents, Itof and Itos, and several delayed rectifiers including
IKr (IK rapid), IKs (IK slow), and IKur (IK ultra-rapid) have
been distinguished (Brunet et al., 2004). The time- and voltage-
dependent properties of Kv currents identified in myocytes from
different species and/or from different regions of the heart
present a remarkable similarity, suggesting that the same (or
very similar) molecular entities contribute to the generation of
each of the various types of Kv channels (Table 1) in different
cells/species.
Voltage-Dependent Potassium Channels
Based on biophysical differences and pharmacological
sensitivities there are two main classes of Kv currents: transient
outward currents (Ito) and delayed rectifier (IK) currents
(Barry and Nerbonne, 1996; Nerbonne and Guo, 2002). The Ito
currents are activated and rapidly inactivated on a depolarization
stimuli (∼ −30mV) and underlie the early phase (phase 1)
of repolarization in ventricular and atrial cells in rat (Apkon
and Nerbonne, 1991), mouse (Benndorf and Nilius, 1998), cat
(Furukawa et al., 1990), rabbit (Hiraoka and Kawano, 1989), dog
(Litovsky and Antzelevitch, 1998), and humans (Varró et al.,
1993; Wettwer et al., 1993). The Ito currents influence Cav
channel activation and the balance between inward and outward
currents during phase 2. Cardiac IK currents are activated
at similar plasma membrane potentials and present variable
kinetics. These currents are determinant for the latter phase of
repolarization that determine the diastolic potential (Barry and
Nerbonne, 1996).
The two components of the Ito currents identified in the heart
cell types show different kinetics of recovery (Xu et al., 1999).
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FIGURE 1 | Impairment insulin signaling in endothelial hyperglycemic environment. In physiological state, insulin induces a signaling pathway that involves the
activation of phosphatidylinositol 3-kinase (PI3K), mitogen activated protein kinase (MAPK), and specificity protein 1 (Sp1). This pathway induces the transcriptional
activity of the SLC7A1 gene and the plasma membrane expression of hCAT-1 for increased the L-arginine transport and nitric oxide (NO) synthesis in endothelial cells.
In hyperglycaemia, insulin resistance causes deterioration of intracellular signaling that reduces the transcriptional activity of SLC7A1, diminishing the L-arginine
transport and NO synthesis. Also the insulin resistance abolishes the antioxidant capacity of the hormone, increasing the reactive oxygen species (ROS) and lowering
the bioavailability of NO through the reaction with superoxide (O−2 ) to form peroxynitrite (ONOO
−).
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FIGURE 2 | Representation of ventricular Action Potential (AP) and the
temporal ionic current contribution. Blue arrow up represents outward
currents, green arrow down represents inward currents. AP have five
well-differenced states: 4, Resting; 0, Upstroke; 1, Early repolarization; 2,
Plateau; 3, Final repolarization. The time- and voltage-dependent properties of
the voltage-gated inward Na+ (Nav) and Ca2+ (Cav) currents expressed in
human atrial and ventricular myocytes are similar. In contrast, there are multiple
types of K+ currents, particularly Kv currents, contributing to ventricular action
potential repolarization. The properties of the various Kv currents are distinct,
and in contrast to the inward currents, there are multiple Kv currents
expressed in individual myocytes throughout the myocardium. IK1, inward
rectifier current; Ito, transient outward current; IK, delayed rectification
currents: Ikur, ultra-rapid; Ikr, rapid; Iks, slow; ICaL, L-type Ca2+ current; Ina,
sodium current; NCX, Na+/Ca2+ exchanger; If, funny current; IKACh,
G-protein-activated K+ current.
The Ito rapid current component (Ito fast, Itof) is recovered
rapidly in the range of 60–100ms (Patel and Campbell, 2005).
In contrast, the slow component (Ito slow, Itos) recovers slowly
with time constants in the order of seconds (Xu et al., 1999). Both
are differentially expressed and contribute to heterogeneity of the
action potential shape (Brunet et al., 2004).
Structurally, Kv channels are comprised of four α subunits
that form the channel pore (MacKinnon, 1991), each subunit
with six transmembrane segments (denoted S1–S6) including
the voltage sensor S4 (Snyders, 1999), a single pore region
between S5 and S6, and C- and N-terminal intracellular domains.
The pore region works as a K+ selectivity filter (Doyle et al.,
1998). In Kv1 to Kv4, the amino acids sequence at the N-
terminal domain, which precedes S1, plays a critical role in
the assembly Kvα subunit (Figure 3) (McKeown et al., 2008).
Evidence suggests that Kv α-subunits of the Kv4 subfamily are
responsible for a rapidly activating, inactivating, and recovering
cardiac transient outward Kv channels referred to as Itof
(Table 1). In rat and mouse ventricular myocytes exposed to
antisense oligodeoxynucleotides targeted against Kv4.2 or Kv4.3,
Itof density is reduced by <50% (Fiset et al., 1997; Guo et al.,
2002). Significant reductions in rat ventricular Itof density are
also seen in cells exposed to an adenoviral construct encoding
a truncated Kv4.2 subunit (Kv4.2ST) that functions as a negative
dominant (Johns et al., 1997). In addition, it has been reported
that Itof is eliminated in ventricular myocytes isolated from
transgenic mice, expressing a pore mutant of Kv4.2, W362F
(Barry et al., 1998). Taken together, these results demonstrate
that members of the Kv4 subfamily underlie Itof in mouse and
rat ventricles. Biochemical studies have also shown that Kv4.2
and Kv4.3 are associated in adult mouse ventricles, suggesting
that functional ventricular Itof reflect the heteromeric assembly
of the Kv4.2 and Kv4.3 α-subunits (Guo et al., 2002). In dog and
human myocardium, however, Kv4.2 appears not to be expressed
(Kong et al., 1998), suggesting that only Kv4.3 contributes to
Itof, in larger mammals. Moreover, the genetic deletion of
Kv4.2 abolishes Itof current, revealing a critical role of Kv4.2
channels in generating these currents in rodents (Guo et al.,
2005).
Biophysical properties of slow transient outward myocardial
Kv currents, referred as Itos, are different. Considerable evidence
supports that myocardial Itos currents are encoded by the Kv1
α-subunit, Kv1.4. Heterologous expression of Kv1.4 yields slowly
recovering (seconds), 4-aminopyridine (4-AP, Kv inhibitor)
sensitive transient Kv currents (Tseng-Crank et al., 1990; Po
et al., 1992; Comer et al., 1994; Wickenden et al., 1999)
that closely resemble Itos (Fermini et al., 1992; Brahmajothi
et al., 1999; Wang et al., 1999; Xu et al., 1999). In addition,
expression of Kv1.4 has been demonstrated at the transcript
level in rat (Tseng-Crank et al., 1990; Roberds and Tamkun,
1991; Wickenden et al., 1999), ferret (Brahmajothi et al.,
1999), canine (Dixon et al., 1996), and human (Tamkun
et al., 1991) hearts, and at the protein level in mouse, rat
and ferret ventricles (London et al., 1998; Brahmajothi et al.,
1999; Wickenden et al., 1999) and rabbit atrium (Wang et al.,
1999). Direct support for this hypothesis was complemented
on myocytes isolated from (Kv1.4−/−) mice with a targeted
disruption in the kcna4 (Kv1.4) locus (London et al., 1998).
Waveforms of outward currents in cells isolated from Kv1.4−/−
ventricles are indistinguishable from those recorded in wild-
type ventricular cells (Guo et al., 1999). In cells isolated from
the interventricular septum from Kv1.4−/−, however, Itos is
undetectable, thereby demonstrating that Kv1.4 underlies Itos
(Guo et al., 1999).
Some studies suggest that additional subunits are required
for the generation of cardiac Ito currents. Indeed, a number of
molecularly diverse accessory subunits can modulate biophysical
properties and cell surface expression of heterologously-
expressed Kv4 channels (Guo et al., 2000; Abbott et al., 2007). Of
these accessory subunits, only the cytoplasmic KChIP2 protein
has been shown directly to be an essential component of
myocardial Itof (Grubb et al., 2012). Co-expression of KChIP
subunits dramatically increases the cell surface expression of Kv4
channels, Itos inactivation andmarkedly accelerates recovery (An
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TABLE 1 | Cardiac currents contributing to action potential repolarization.
Channel Protein Gen Cardiac Activation Inactivation Recovery Species Tissue References
type current
Nav
Nav1.5 SCN5A INa Very Fast Fast Fast Cat, dog, ferret,
human, mouse, rat
A, P, V, SAN,
AVN
Antzelevitch and Dumaine,
2002
Cav
Cav1.2
(α1.2)
CACNA1C ICa (L) Fast Moderate Fast Cat, dog, ferret,
human, mouse, rat
A, P, V, SAN,
AVN
Bers and Perez-Reyes,
1999
Cav3.1 CACNA1G ICa (T) Fast Fast Fast Cat, dog, guinea
pig, rat
A, P, SAN,
AVN
Perez-Reyes, 2002
Kv
Kv4.2 KCND2 Ito, f Fast Fast Fast Cat, dog, ferret,
human, mouse, rat
A, P, V Apkon and Nerbonne,
1991; Varró et al., 1993;
Wettwer et al., 1993; Barry
and Nerbonne, 1996; Patel
and Campbell, 2005
Kv4.3 KCND3 Ito, s Fast Moderate Slow Ferret, human,
mouse, rat, rabbit
V Tseng-Crank et al., 1990;
Po et al., 1992; Comer
et al., 1994; Wickenden
et al., 1999; Xu et al., 1999;
Nerbonne, 2000
erg1 KCNH2 IKr Moderate Fast Cat, dog, human,
mouse, rabbit, rat
A, P, V, SAN,
AVN
Delmar, 2004; Nerbonne
and Kass, 2005
KvLQT1 KCNQ1 IKs Very Slow No Dog, guinea pig,
human, rabbit
A, P, V, SAN Nerbonne and Guo, 2002;
Delmar, 2004
Kv1.5 KCNA5 IKur Very Fast Very Slow Dog, human A,V Xu et al., 1999; Nielsen
et al., 2007; Sridhar et al.,
2007; Calloe et al., 2010
IK, slow1 Slow Slow Mouse A, V Boyle and Nerbonne, 1992;
Wang et al., 1993; Brunet
et al., 2004
Kv2.1 KCNB1 IK, slow2 Very Slow Very Slow Mouse A, V Munk et al., 1996
K2P
TREK-1 KCNK2 Iss Slow No Rat A, V, AVN Luo and Rudy, 1994a,b
Kir
Kir2.1 KCNJ1 IK1 Cat, dog, ferret,
human, mouse,
rabbit, rat
A, P, V Luo and Rudy, 1994a,b
A, atrial; P, Purkinje; V, ventricular; SAN, sinoatrial node; AVN, atrioventricular node. The dashed boxes are placed around current given different names in different species that likely are
encoded by the same channel’s subunit genes.
et al., 2000). Also, KChIP2 co-immunoprecipitates with Kv 4.2
(and Kv4.3) α subunits in adult mouse ventricles (Guo et al.,
2002) and the targeted deletion of the KChIP2 locus (kcnip2)
abrogates ventricular Itof (Kuo et al., 2001). Interestingly,
KChIP2 protein expression is dramatically reduced in Kv4.2−/−
ventricles (Guo et al., 2005), suggesting that expression of the Kv4
and KChIP2 proteins are reciprocally regulated. Other regulatory
subunit that colocalize with Kv4.2 is the MinK-related peptide
(MiRP) (McCrossan and Abbott, 2004; Roepke et al., 2008).
Although MiRP does not affect the densities of expressed Kv4.2-
KChIP2 currents (Liu et al., 2008), targeted deletion of the
gene encoding MiRP result in reduced (<25%) ventricular Itof
densities without changes in total or surface Kv4.2 expression
(Roepke et al., 2008).
The ultra-rapid potassium current IKur is well expressed in
the atria, where it contributes to repolarization (Amos et al.,
1996). The molecular constituent of IKur is the Kv1.5 potassium
channel (Boyle and Nerbonne, 1992; Wang et al., 1993). Direct
experimental support for this hypothesis was provided with
the demonstration that exposure to antisense oligonucleotide
targeted against Kv1.5 selectively attenuates IKur in isolated adult
human (Snyders et al., 1993; Feng et al., 1997) and rat atrial
myocytes (Bou-Abboud and Nerbonne, 1999). The important
physiological role for Kv1.5 in human atria is suggested by
the finding that IKur densities and Kv1.5 protein expression
are reduced markedly in atria of patients with chronic atrial
fibrillation (Van Wagoner et al., 1997). Although, IKur has
predominantly been reported in atria, it has also been suggested
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FIGURE 3 | Predicted protein topology of cardiac K+−channel α
subunits. Schematic representations of (A) the six-transmembrane (S1–S6)
one P-loop (6Tm-1P) voltage-dependent K+−channel (Kv) α-subunits
topology that conduct IKur, Ito, Iks, IKr, and If in the heart; in red voltage
sensor (S4); in green the pore region formed by S5 and S6 segments. Note
the amino (NH2) and carboxyl (COOH) terminal tails located intracellular, which
serves as assembly sites for β-subunits as KCHiP2. (B) Structure of the
tetrameric assembly of the Kv Channel viewed from the extracellular side. The
S5-P-loop-S6 region assembles with three other pore domains (central P)
functions as a K+ selectivity filter.
to play a role in canine and human ventricles (Nielsen et al., 2007;
Sridhar et al., 2007; Calloe et al., 2010).
Insulin Regulation of Cardiac Electrical
Function
Insulin has a direct effect in cardiomyocytes, in glucose transport
and oxidation, glycolysis, glycogen and protein synthesis (Abel,
2004; Bertrand et al., 2008). In vivo, many of insulin’s effects
on cardiac function and metabolism are related to systemic
responses such as an increment in peripheral and coronary
vasodilatation, and sodium and water intake by the kidney
(Muniyappa et al., 2007).
Insulin is a key regulator of cardiac growth as reported in
studies carried out in cardiac insulin receptor knockout (CIRKO)
mice. In this study, the cardiac index was reduced by 22–
28%, possibly due to a decrease in myocyte size rather than a
reduction in cell number (Belke et al., 2002). The role of insulin
in cell size regulation is supported by studies in Drosophila
with disrupted homolog of vertebrate insulin signaling, were the
knock-out model for IRS, had less than half the size of wild-
type flies, owing to fewer and smaller cells (Böhni et al., 1999).
In experimental mice with targeted deletion of IRS-1 or IRS-
2, there has been evidence of a reduction in postnatal cardiac
size (Araki et al., 1994), which is indicative of conserved roles
for insulin signaling in the determination of cardiac growth.
Inhibition of PI3K function in mouse heart using a negative
dominant transgene, results in a similar phenotype generated
in CIRKO mice (Shioi et al., 2000). Negative dominant PI3K
transgenic mice showed 16% reduction in cardiac index and
myocyte surface area reduction of 18% (Belke et al., 2002). Thus,
impaired PI3K activity represents a mechanism that explains the
cardiac size phenotype in CIRKO mice.
In addition, insulin could increase cardiac contractility,
affecting cardiac output, and mediates the cellular hypertrophy
and generates an antiapoptotic effect on cardiomyocytes by
activating other intermediary intracellular signaling pathways
(Belke et al., 2002). Changes in these pathways and in the
pathologic processes linked to status of insulin deficiency or
insulin resistance could contribute to an increased risk of cardiac
hypertrophy, pathological remodeling of the left ventricle and
heart failure, among others (Cesario et al., 2006).
Diverse evidences suggests that the stimulatory effect of
insulin involves K+ channel protein synthesis, which is
responsible for maintaining both Ito and IKur currents;
although it is proposed that the hormone regulates differentially
these two currents (Shimoni et al., 1998; Rozanski and Xu,
2002; Lengyel et al., 2007; Torres-Jacome et al., 2013). In a
recent review, Ballou et al. collected and summarized several
studies that shows that PI3K signaling regulates many aspects
of proteins involved in AP in the heart, including protein
expression, trafficking and gating Nav1.5, Kv11.1, Kv7.1, and
Cav1.2 in cardiomyocytes. This evidence comes from studies
where drugs that inhibit PI3K signaling cause QT prolongation,
but the role of PI3K in transcriptional regulation of genes
in cardiomyocytes is relatively unexplored (Ballou et al.,
2015).
However, a study of isolated cardiomyocytes from T1DM
mice induced by STZ and treated with wortmannin (inhibitor
of PI3K) prior to incubation with insulin, showed that insulin
is still able to restore the densities of Ito currents without effect
on other potassium currents (Ui et al., 1995). This indicates
that this hormone could not induce its effects through PI3K
pathway in T1DM (Shimoni et al., 1998). Insulin stimulates
another important signaling pathway, MAPK/ERK, which can
lead to cell proliferation and protein synthesis (Guo, 2014);
furthermore, its activation can be blocked by PD98059, a specific
inhibitor of the phosphorylation of ERK1/2 (Lazar et al., 1995). In
isolated cardiomyocytes from T1DM rats treated with PD98059
(30min) prior to the addition of insulin, blockage is perceived
in the insulin-dependent return of the densities of potassium Ito
currents (Shimoni et al., 1998). These results suggest that the
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effects on the maintenance of these currents and their respective
channels occur in a MAP-kinase dependent process (Shimoni
et al., 1998).
Cardiac Disease in Diabetes Mellitus
Studies have found that diabetic patients have an increased
risk of CVD (Gregg et al., 2014). Common complications are
acute myocardial infarction (181.5 events/1000 people/year) and
stroke (126.2 events/1000 people/year; Bethel et al., 2007). In
a cohort of geriatric American adults with T2DM between
2004 and 2010, cardiovascular complications have the highest
incidence, followed by eye disease and hypoglycaemic events
(Huang et al., 2014). The presence of diabetes is associated with
a high risk of cardiac failure (Aneja et al., 2008), and is present
in the 75% of patients with idiopathic dilated cardiomyopathy
(Bertoni et al., 2003). The “Framingham Heart” Study (Kannel
and McGee, 1979) showed that the incidence of heart failure is
2 and 5 times higher for diabetic men and women, respectively.
Diabetic patients with macrovascular complications showed a
strong association with cardiomyopathy, and its association is
well correlated with the duration and severity of hyperglycaemia
(Poornima et al., 2006).
Diabetic Cardiomyopathy
DM affects cardiac structure and function, which under certain
conditions can lead to a condition called DCM. Rubler et al.
described this condition first in 1972 and defined it as
“ventricular dysfunction that occurs independently of coronary
artery disease and hypertension” (Rubler et al., 1972). In addition,
DCM is characterized by diastolic dysfunction, which becomes
more apparent in presence of hypertension or myocardial
ischemia (Fang et al., 2004). In humans, the DCM is also
characterized by diastolic dysfunctions, which precede the
development of systolic dysfunction (Liu et al., 2001). These
findings also could be found in patients with T2DM, where
diastolic dysfunction affected 30% of the patients (Boudina and
Abel, 2007).
The effects of DCM lead to cardiomegaly, left ventricular
dysfunction, ventricular electrical remodeling and symptoms
of congestive heart failure (Casis et al., 2000). The resulting
electrophysiological changes contribute to an increase in the
incidence of cardiac arrhythmias and sudden death (Casis et al.,
2000). Electrical changes have been associated with the surface
ECG abnormalities, including T and QT wave prolongation
(Casis et al., 2000; Casis and Echevarria, 2004).
Insulin resistance in the heart is a factor that contributes
significantly to DCM (Mandavia et al., 2013). Therefore, it
is important to distinguish between the secondary effects to
environmental disturbances in states of insulin resistance and
specific changes that occur in the signaling pathways that are
intrinsic to heart tissue. These effects determine, among others,
changes in cardiomyocyte AP as might be the extension of
repolarization phase (Lengyel et al., 2007), and thus infer the
pathophysiological mechanism that would play insulin on heart
function.
Morphological Changes in the Ventricular
Action Potential
The morphology of AP is clearly altered in T1DM and T2DM,
showing a prolonged QT in myocytes isolated from STZ models
in either, mice (Magyar et al., 1992; Casis et al., 2000) or rabbits
(Torres-Jacome et al., 2013). AP duration in cells stimulated
at 1Hz increases in isolated cells from diabetic mice (Casis
et al., 2000). These cells shown, phase 1 (early repolarization)
less pronounced and a longer phase 2 (plateau). Otherwise,
the resting membrane potential and the AP amplitude were
unchanged (Casis et al., 2000). Moreover, T2DM models (db/db
mice, a leptin receptor mutant that develops obesity, diabetes,
hyperinsulinemia and increased levels of triglycerides and fatty
acids; Buchanan et al., 2005) shown similar prolongation of
action potentials (Figure 4) (Shimoni, 2001).
Prolongation of action potentials is due to, at less in part,
by a decrease in the output repolarizing currents (Ito and IK)
(Shimoni et al., 1999, 2004; Qin et al., 2001). The amplitude
of the currents (Ito and IK) are reduced in myocytes isolated
from T1DM murine models (Torres-Jacome et al., 2013). In
addition, myocytes isolated from db/db mice (12th week of age),
as a T2DM model, exhibit a sustained attenuation of the output
currents compared to the db/+ mouse (Shimoni, 2001; Shimoni
et al., 2004). Therefore, despite the dramatically different levels of
insulin circulating in the STZ diabetic rat and db/db mouse, the
changes of action potential and ventricular output K+ currents
are similar, suggesting that these effects could be generated by an
impaired ligand-receptor coupling or absence of insulin signaling
pathway (Shimoni et al., 2004).
Despite the total output currents of K+ are impaired
(Figure 4), is necessary to determine which one is most relevant
electrical change. In dogs treated with alloxan (a toxic glucose
analog that destroys the β-pancreatic cells) to induce T1DM,
after 8 weeks, were evaluated the different currents contribution
to the AP through voltage-clamp experiments. In this case, no
changes were found in neither amplitude nor voltage-dependent
IKr and ICa activation currents. Conversely, the amplitude of the
Ito and IKur currents significantly decreased by 69.3 and 54.6%
in myocyte cells isolated from diabetic models, respectively. In an
effort to clarify the effects of insulin, after a week from developed
diabetes, dogs were treated with insulin (0.5–1.0 IU/kg day-1s.c),
and an increase in current density was evident only in the Ito
and IKur currents (Lengyel et al., 2007). This result is consistent
with findings obtained from myocytes isolated from hearts of
diabetic mice (STZ model) incubated with insulin, in which the
amplitudes of these currents were restored (Magyar et al., 1992;
Xu et al., 1996, 2002; Shimoni et al., 1998).
Several animal models have been used to characterize the
effects of diabetes on the heart (Shimoni et al., 2004; Boudina
and Abel, 2010) and include a variety of systemic effects
(Bugger and Abel, 2009). Diminished glucose oxidation rates
in cardiomyocytes occur as early as 48 h after the induction of
diabetes by STZ treatment, which is reversed by insulin treatment
(Chen et al., 1984). Insulin-stimulated cardiac glucose uptake
and their utilization are also impaired in type 2 diabetic hearts
(Mazumder et al., 2004). Furthermore, in hyperinsulinemic
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FIGURE 4 | Morphological changes associated to impaired insulin in
different experimental models: T1DM, T2DM, and CIRKO. (A)
Representative whole cell voltage-gated outward K currents recorded from
Wild-type (WT) animal (left) and impaired insulin signaling condition (right).
Outward K+ currents are reduced in ventricle of experimental models. (B)
Representative action potentials waveforms recorded from left ventricular
myocytes isolated from WT (solid red line) and experimental mice (dashed red
line). Insulin signaling alterations produce a prolonged action potential duration
(APD) in experimental ventricular cells. Effect of absent or impaired cardiac
insulin signaling at the level of the whole organism by measuring surface ECG
activity in anesthetized mice. In (C) is illustrate the comparison of ECG
recordings from WT and experimental mice. Analyses of the ECG parameters
confirmed a significant prolongation mainly in QT intervals in experimental
relative to control littermates. Relative differences in QT intervals are indicated
below the records by red solid lines.
animal models of T2DM, such as the Zucker diabetic rat, the
impaired insulin signal transduction in cardiac muscle (Kolter
et al., 1997) is also associated with diminished glucose utilization
and increased fatty acid utilization in the heart (Chatham,
2001). In all of these models it is difficult to separate the
relative contribution of intrinsic defects in cardiomyocyte insulin
signaling from the conditions generated by the altered systemic
metabolism, such as hyperglycaemia and hyperlipidaemia.
The cardiac-specific insulin receptor knockout (CIRKO) mice
model, development by cre/loxP recombination to specifically
inactivate insulin signaling in cardiomyocytes in vivo, preserve
insulin signaling in other cells such as endothelial cells, VSMC,
and liver and skeletal muscle cells (Brüning et al., 1998; Abel et al.,
1999) and let to investigate the specific role of impaired cardiac
insulin signaling without the additional conditions associated to
systemic metabolic perturbations (Belke et al., 2002). CIRKO
mice develop contractile dysfunction but not heart failure,
associated with decreased glucose and fatty acid oxidation (Belke
et al., 2002). Also develop mitochondrial dysfunction, with an
increased mitochondrial superoxide production, and display
fatty acid-induced mitochondrial uncoupling (Boudina et al.,
2009). Likewise, CIRKO mice represent a useful model to dissect
the mechanisms and the effects of insulin in the heart, in the
absence of systemic effects of insulin deficiency, or the additional
conditions associated to systemic effects of insulin treatment as
occur in many models of diabetes.
Effects of Diabetes on Gene Expression of
Kv Channels
Decreased of outward currents induced by diabetes conditions
may be attributed to deficient protein expression (Howarth
et al., 2009), changes in biophysical properties, or both (Lopez-
Izquierdo et al., 2014). Until now, there is no difference in voltage
dependence of inactivation, inactivation kinetics, or recovery
from inactivation state. It is suggested that these effects are
explained by an abnormal protein expression (Lopez-Izquierdo
et al., 2014).
The study of the cardiac gene expression by RT-PCR
considering the genes: kcnd2 and kcnd3 encoding the Ito
α-subunit Kv4.2 and Kv4.3, respectively (Frank-Hansen et al.,
2005); kcne2 encoding to MiRP1, Ito and IKs β-subunit (Roepke
et al., 2008), on tissue extracted from left ventricles of mice with
STZ-induced diabetes showed significant reductions of ∼80%
in the expression of kcnd2 and kcne2, whereas no significant
differences were shown for kcnd3 (Howarth et al., 2009). These
results were replicated in CIRKO mice, where KChIP2, Kv4.2
accessory subunit had about 50% reduction. Therefore, Kv4.2
and its assembly with specific accessory subunits such KChIP2
and MiRP1, would be relevant in maintaining transient K+
current, mainly in its fast component (Itof) (Lopez-Izquierdo
et al., 2014).
Studies in animal models of diabetes also reveal a reduction
in the mRNA and protein levels of the components of Itof (Qin
et al., 2001). Based on the analysis of protein levels of ion channels
evaluated by western blot obtained for CIRKOmice left ventricle,
show a reduction of ∼50% in the abundance of Kv4.2 and Kv1.5
(Lopez-Izquierdo et al., 2014). In contrast, other studies using a
T1DM rat or CIRKO mice model, report a reduction in Kv4.2
protein expression, but not for the Kv4.3 channel, were neither
the messenger nor protein expression were down-regulated
(Kääb et al., 1998; Nishiyama et al., 2001). KChIP decreased
by 40% when compared to the control group (Lopez-Izquierdo
et al., 2014). Furthermore, immunofluorescence analysis shows
a reduction of immunoreactivity for Kv4.2, Kv4.3, and Kv1.5
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protein, in isolated ventricular cardiomyocytes from T1DM
models vs. healthy controls, and no changes of Kv2.1 (IKr
determining protein) were found (Torres-Jacome et al., 2013).
Moreover, in extracted tissue from ventricles of diabetic animals
evaluated by immunohistochemistry, a reduction has been
shown in the number of cardiomyocytes with immunopositive
reactivity to Kv4.2 and MiRP1 (IKur β-subunit), consistent
with the reduced expression genes that encode them (Howarth
et al., 2009). Therefore, a reduction in Kv4.2, Kv1.5 messenger
and protein provides an explanation for the reduced Ito
and IKur currents, observed in impaired insulin signaling
conditions, respectively. At the same time, interaction with
accessory subunits, such as KChiP2 and MiRP-1, would be
relevant to the maintenance of these currents (Grubb et al.,
2012).
In addition, the results previously mentioned suggest a
regulatory role of insulin in the expression of different potassium
channels in diabetic cardiomyocytes. Incubation of isolated
myocytes with insulin can recover the protein expression of
Kv4.2 and Kv1.5 channels, and also restores the amplitude of
potassium currents when tested after 3, 4, 5, and 6 h incubation
(Shimoni et al., 1998). In the same way, the use of protein
synthesis blockers, such as cycloheximide, blocks these currents’
recovery (Rozanski et al., 1998). Furthermore, the effect of insulin
depends on the integrity of the cytoskeleton, hence protein
traffic inhibitors, as cytochalasin D, are able to attenuate this
effect (Shimoni et al., 1999; Yang et al., 2002). Presumably,
it is necessary that newly synthesized channels can effectively
translocate to the cell membrane to maintain these specific
repolarizing currents.
CLINICAL IMPLICATIONS
Insulin is a hormone with pleiotropic physiological functions, so
it is normal to conclude that deterioration of insulin signaling
also has pleiotropic dysfunctions. In this review, we discuss two
main mechanism that govern the cardiovascular physiology, one
mechanism in endothelial cell related with L-arginine transport
and NO bioavailability, and a second main mechanism related
with the regulation of Kv channels on cardiomyocytes.
The physiological role of NO is well known in human
vasculature, so the largest contribution of this review is the
establishment that insulin resistance is closely related with
potential reduction of hCAT-1 expression and/or activity in
endothelial cells. Reduction of L-arginine transport is a primarily
cause of endothelial dysfunction and induces a reduction of NO
synthesis due to restriction of substrate availability for eNOS.
Cardiovascular pathologies associated to insulin resistance are
well documented, and we propose that the significant reduction
of L-arginine transport mediated by lower expression and/or
alteration of plasma membrane localization of the transporter
could be a link between the impairment of insulin signaling and
vascular disease. Clinical evidence shows that the forearm L-
arginine uptake is reduced in subjects with essential hypertension
or with family history of hypertension. In peripheral blood
mononuclear cells (PBMCs) isolated from the same patients, a
reduction was seen of Vmax of L-arginine transport and lower
sensitivity to Ach-dependent vasodilatation, parameter that was
reverted by co-infusion of L-arginine (Schlaich et al., 2004).
Also a reduction in agonist-induced blood flow was observed in
response to insulin in patients with T2DM, an alteration that
is associated to lower capacity of transport of L-arginine and
NO synthesize (Rajapakse et al., 2013). Additionally, in CHF
patients it is determined that there is a reduced capacity for
transport of L-arginine from plasma to the tissues with reduction
of transcardiac fractional extraction of L-arginine and lower
expression of hCAT-1 in myocardial tissue, without changes in
hCAT-2B expression. Also the transcardiac L-citrulline flux, as
a parameter of NO synthesis in heart, is decreased in CHF
patients (Kaye et al., 2002). These data indicate the presence of
an abnormal L-arginine transport in CHF, suggesting a shared
mechanism between endothelial dysfunction and heart disease,
related with hCAT-1 down-regulation and impairment of NO
synthesis.
Altogether, this information demonstrates that there is a
positive feedback mechanism between insulin secretion, insulin
signaling, L-arginine/NO pathway, and cardiac function that is
disrupted in pathophysiological conditions such as metabolic
syndrome, insulin resistance and diabetes.
In regards to the physiological role of insulin in the regulation
of Kv channels and their association with cardiac electrical
function specifically, this relationship would be given by an
altered intracellular signaling in a similar way to the pathological
processes involved in diabetes mellitus (Casis and Echevarria,
2004). Diabetic patients show electrocardiographic changes
associated with a high incidence of cardiac arrhythmias (Veglio
et al., 1999, 2002a,b, 2004). Specifically, long QT syndromes
(duration of ventricular depolarization and repolarization of the
myocardium) have been reported as a result of an increase in the
time of the ventricular action potential. This phenomenon has
been linked to a three-fold increased risk of sudden cardiac death
(Straus et al., 2006). Evenmore, studies have shown a significantly
increase in relative death risk for subjects with QTc (QTc, heart
rate-corrected QT interval) longer than 0.43–0.44 s (Brown et al.,
2001). This relationship has been shown for all cause mortality,
cardiac mortality, and sudden death (Festa et al., 2000).
Prevalence of QTc prolongation has been evaluated in
different cohorts of diabetic subjects (Veglio et al., 1999, 2002a,b)
and in the National Health and Nutrition Examination Survey
III (NHANES III) population (Brown et al., 2001; Zhang et al.,
2011). In T1DM patients, the prevalence of an abnormally
prolonged, corrected QT was 16% in the whole population, 11%
in males and 21% in females. QTc in insulin-dependent diabetic
female patients is longer than in male patients, even in the
absence of diabetic complications known to increase the risk of
corrected QT prolongation (Veglio et al., 1999). While in T2DM
patients, prevalence of increased QTc duration was 25.8%, with
no sex differences, showing a considerably high prevalence of
increased QTc and their association with Coronary Heart Disease
(Veglio et al., 2002a,b). Finally, in the NHANES III survey, the
prevalence of QTc prolongation in diabetic subjects was nearly
twice that of non-diabetic subjects (Brown et al., 2001; Zhang
et al., 2011).
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Different studies explain the action potential prolongation
as a response to a reduction of repolarizing K+ currents, in
cardiomyocytes isolated from type 1 to 2 diabeticmodels (Magyar
et al., 1992; Shimoni et al., 1994; Casis et al., 2000; Shimoni,
2001; Torres-Jacome et al., 2013). To examine the effects of
impaired insulin signaling on these electrophysiological changes,
recent studies have measured the electrocardiographic activity
in anesthetized CIRKO mice, in order to assess the effect of the
lack of cardiomyocyte specific insulin receptor (Lopez-Izquierdo
et al., 2014). When was compared the electrocardiographic
recordings from CIRKO mice vs. control mice, it has been
demonstrated a significant prolongation of the QRS, QT, andQTc
intervals (Lopez-Izquierdo et al., 2014).
The specific contribution of impaired insulin signaling in
gene expression for cardiac Kv channels, lead to a QT interval
prolongation in experimental models (Figure 5) (Howarth et al.,
2009). This is similar to the findings that were reported for
diabetic patients (Veglio et al., 2002a,b). These results are
independent of the systemic metabolic changes that join the
disease.
CONCLUDING REMARKS
In summary, insulin has general effects on all tissues and a
strong relationship with cardiovascular function. Specifically,
through experimental models of impaired intracellular
signaling, which occurs in pathological conditions such as
diabetes, it is possible to elucidate the regulatory effects
that tie this particular ligand to the vascular and cardiac
function.
Diabetes involves a series of prevalent cardiovascular
complications such as DCM, a disease that appears as relevant
for studying the effects of insulin resistance. This is because it
includes a number of pathophysiological events, which include
the ventricular electric remodeling.
Insulin plays an important role in maintaining the current
repolarizing, specifically the Ito and IKur components, which
determine the appropriate action potential in ventricular
cells. This regulation is achieved through genes and
proteins expression, which determine the Kv4.2 and Kv1.5
α subunits, β subunits and KChIP2 and MiRP1 composition,
FIGURE 5 | Proposal model of Insulin regulation of cardiac Kv channels. Normal cardiac Insulin signaling (right side) plays an important role in maintaining the
repolarizing currents, in a Ras/MAP Kinase signaling pathway-mediated process. This regulation is achieved through gene expression and protein, which, specifically,
determine the Kv4.2 and Kv1.5 α subunits, were need translocate to cellular membrane to generate Ito and IKur currents, which determine the appropriate action
potential in ventricular cells. Furthermore, in disease, impaired insulin signaling (left side) and the reduce Ito and IKur currents amplitude, leads to an increase in the
length of AP, manly in phase 2, due to the reduced availability of Kv channels with an increased risk of cardiac arrhythmias associated.
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in a Ras/MAP Kinase signaling pathway-mediated process
(Figure 5).
Outside of metabolic function, it is also evidenced that insulin,
through the lack of its signaling pathways, plays a regulatory
role in the cardiac electrical activity through voltage-dependent
potassium channels and can produce electrocardiographic
changes, such as QT prolongation, and increased risk of sudden
death in diabetic patients.
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